Professional Documents
Culture Documents
ISentium Dec 22
ISentium Dec 22
ISentium Dec 22
GILD (Gilead Sciences Inc.) A deal announced this morning grants AbbVies hepatitis C
treatment exclusivity with Express Scripts and therefore removes Gileads blockbuster drug
Sovaldi as a treatment option for patients of the largest US prescription-drug benefit manager.
Express Scripts cited a favorable discount reached for AbbVies competing treatment, which is
priced about $10,000 cheaper than Gileads drug but requires six pills per day instead of one.
Gilead experienced deteriorating sentiment early this morning on the announcement, with
predominantly negative chatter generating a bearish iSENSE alert at 8:20AM. GILD is down
almost 11% in the pre-market.
_____________________________________________________________________________________________________________________
Copyright 2014, iSENTIUM, LLC. All Rights Reserved
NPO (EnPro Industries, Inc.) - EnPro Industries, Inc., the $2 billion industrial products
manufacturer, announced this morning the acquisition of Fabrico, Inc a manufacturer of
turbine technology and products in an all-cash deal for an undisclosed sum. With this move,
EnPro looks to expand its product offering for turbines used in land-based industrial operations.
This mornings sentiment was consistently positive for NPO, and it produced a bullish iSENSE
alert at 8:00AM. NPO is up slightly in early hours trading.
CHKP (Check Point Software Technologies Ltd.) A week after a significant upgrade from
Deutsche Bank research, Check Point Software the $15 billion IT communications firm had
its price target raised by Oppenheimer this morning. Oppenheimer upgraded a range of
companies in the space, citing increased concerns and demand for traditional and cloud-based
security solutions in light of the Sony hacking and other recent information breaches.
Overwhelming positive sentiment created a bullish iSENSE alert at 8:29AM, and CHKP is up in
early hours trading.
_____________________________________________________________________________________________________________________
Copyright 2014, iSENTIUM, LLC. All Rights Reserved